BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26880578)

  • 21. Identification of a conserved linear B-cell epitope in the Staphylococcus aureus GapC protein.
    Wang M; Wei Y; Yu W; Wang L; Zhai L; Li X; Wang X; Zhang H; Feng Z; Yu L; Yu Y; Ma J; Cui Y
    Microb Pathog; 2018 May; 118():39-47. PubMed ID: 29522802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus.
    Nanra JS; Buitrago SM; Crawford S; Ng J; Fink PS; Hawkins J; Scully IL; McNeil LK; Aste-Amézaga JM; Cooper D; Jansen KU; Anderson AS
    Hum Vaccin Immunother; 2013 Mar; 9(3):480-7. PubMed ID: 23249887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.
    McAdow M; Kim HK; Dedent AC; Hendrickx AP; Schneewind O; Missiakas DM
    PLoS Pathog; 2011 Oct; 7(10):e1002307. PubMed ID: 22028651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo.
    Vernachio JH; Bayer AS; Ames B; Bryant D; Prater BD; Syribeys PJ; Gorovits EL; Patti JM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):511-8. PubMed ID: 16436704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections.
    McAdow M; Missiakas DM; Schneewind O
    J Innate Immun; 2012; 4(2):141-8. PubMed ID: 22222316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T; Farnebo F; Szekely L; Flock JI
    APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).
    Pancari G; Fan H; Smith S; Joshi A; Haimbach R; Clark D; Li Y; Hua J; McKelvey T; Ou Y; Drummond J; Cope L; Montgomery D; McNeely T
    Front Cell Infect Microbiol; 2012; 2():36. PubMed ID: 22919628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection.
    Cook J; Hepler R; Pancari G; Kuklin N; Fan H; Wang XM; Cope L; Tan C; Joyce J; Onishi J; Montgomery D; Anderson A; McNeely T
    Hum Vaccin; 2009 Apr; 5(4):254-63. PubMed ID: 18787395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
    Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
    Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of antigenic epitope of Staphylococcus aureus ClfA adhesin.
    Li Y; Liu YH; Li ZJ; Li YG; Liu MY; Liu LB; Wang XG; Wang XL; Suo J; Han WY
    Res Vet Sci; 2013 Jun; 94(3):490-5. PubMed ID: 23178048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.
    Brown M; Kowalski R; Zorman J; Wang XM; Towne V; Zhao Q; Secore S; Finnefrock AC; Ebert T; Pancari G; Isett K; Zhang Y; Anderson AS; Montgomery D; Cope L; McNeely T
    Clin Vaccine Immunol; 2009 Aug; 16(8):1095-104. PubMed ID: 19553551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential epitope recognition in the immunodominant staphylococcal antigen A of Staphylococcus aureus by mouse versus human IgG antibodies.
    Koedijk DGAM; Pastrana FR; Hoekstra H; Berg SVD; Back JW; Kerstholt C; Prins RC; Bakker-Woudenberg IAJM; van Dijl JM; Buist G
    Sci Rep; 2017 Aug; 7(1):8141. PubMed ID: 28811514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy.
    Paterson MJ; Caldera JR; Nguyen C; Sharma P; Castro AM; Kolar SL; Tsai CM; Limon JJ; Becker CA; Martins GA; Liu GY; Underhill DM
    PLoS Pathog; 2020 Aug; 16(8):e1008733. PubMed ID: 32817694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phagocytosis and killing of Staphylococcus aureus by human neutrophils.
    Lu T; Porter AR; Kennedy AD; Kobayashi SD; DeLeo FR
    J Innate Immun; 2014; 6(5):639-49. PubMed ID: 24713863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.